SCHEMBL1886980

SCHEMBL1886980

CC1(C)CN(S(=O)(=O)c2cc(F)cc(F)c2)Cc2c(NC(=O)c3ccc(N4CCOCC4)cc3NC(=O)CN3CCCCC3)n[nH]c21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 5/20 0.48
NTRK1 P04629 7/20 0.48
NTRK3 Q16288 5/20 0.48
NTRK2 Q16620 5/20 0.48
ALDH1A1 P00352 5/20 0.41
MAPT P10636 4/20 0.41
KDM4E B2RXH2 3/20 0.41
RECQL P46063 2/20 0.41
GLA P06280 2/20 0.40
GAA P10253 2/20 0.40
POLB P06746 2/20 0.40
LMNA P02545 1/20 0.40
EIF4H Q15056 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HTT P42858 2/20 0.39
INSR P06213 2/20 0.39
ALK Q9UM73 2/20 0.39
PLK4 O00444 1/20 0.38
AURKA O14965 1/20 0.38
DAPK3 O43293 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1894130 0.93 IGF1R (0.57) IGF1RNTRK1NTRK3NTRK2INSR
SCHEMBL1889053 0.88 IGF1R (0.61) IGF1RNTRK1NTRK3NTRK2ALDH1A1
SCHEMBL1892997 0.87 NTRK1 (0.42) IGF1RNTRK1ALDH1A1MAPTLMNA
SCHEMBL1884822 0.86 IGF1R (0.50) IGF1RNTRK1NTRK3NTRK2INSR
SCHEMBL1885922 0.86 IGF1R (0.48) IGF1RNTRK1NTRK3NTRK2ALDH1A1
SCHEMBL1888755 0.86 IGF1R (0.48) IGF1RNTRK1NTRK3NTRK2ALDH1A1
SCHEMBL2678535 0.86 NTRK1 (0.52) IGF1RNTRK1NTRK3NTRK2INSR
SCHEMBL1884862 0.86 IGF1R (0.49) IGF1RNTRK1NTRK3NTRK2INSR
SCHEMBL1886641 0.86 INSR (0.52) IGF1RNTRK1NTRK3NTRK2INSR
SCHEMBL1891386 0.85 IGF1R (0.48) IGF1RNTRK1NTRK3NTRK2INSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173659-B2 Substituted pyrazolo[4,3-C]pyridine derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-05-08 US disclosed
US-20110230470-A1 SUBSTITUTED PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-09-22 US disclosed
US-7947686-B2 Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-05-24 US disclosed
US-20090023745-A1 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-01-22 US disclosed
EP-1968976-A1 SUBSTITUTED PYRAZOLO [4,3-C] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2008-09-17 EP disclosed
WO-2007068619-A1 SUBSTITUTED PYRAZOLO [4,3-C] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2007-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230470-A1 SUBSTITUTED PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS MAP3K3, MAP3K1, MAP3K19 IGF1R 760/4885NTRK1 1131/4885NTRK3 925/4885
US-20090023745-A1 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors MAP3K3, MAP3K1, MAP3K19 IGF1R 760/4885NTRK1 1131/4885NTRK3 925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.